参考文献/References:
[1]刘宝辉,董慧敏,胡伟国,等.脑胶质瘤多学科诊疗模式的必要性及策略[J].中国临床神经外科杂志,2020,25(10):731-733.[2]Li X,Meng Y.Construction of a SUMOylation regulator-based prognostic model in low-grade glioma[J].J Cell Mol Med,2021,25(12):5434-5442.[3]Trixl L,Lusser A.The dynamic RNA modification 5-methylcytosine and its emerging role as an epitranscriptomic mark[J].Wiley Interdiscip Rev RNA,2019,10(1):e1510.[4]Chen X,Li A,Sun BF,et al.5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs[J].Nat Cell Biol,2019,21(8):978-990.[5]Okamoto M,Hirata S,Sato S,et al.Frequent increased gene copy number and high protein expression of tRNA (cytosine-5-)-methyltransferase (NSUN2) in human cancers[J].DNA Cell Biol,2012,31(5):660-671.[6]Frye M,Dragoni I,Chin SF,et al.Genomic gain of 5p15 leads to over-expression of Misu (NSUN2) in breast cancer[J].Cancer Lett,2010,289(1):71-80.[7]Chen RX,Chen X,Xia LP,et al.N(6)-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis[J].Nat Commun,2019,10(1):4695.[8]Li Y,Li J,Luo M,et al.Novel long noncoding RNA NMR promotes tumor progression via NSUN2 and BPTF in esophageal squamous cell carcinoma[J].Cancer Lett,2018(430):57-66.[9]Ritchie ME,Phipson B,Wu D,et al.limma powers differential expression analyses for RNA-sequencing and microarray studies[J].Nucleic Acids Res,2015,43(7):e47.[10]Manning M,Jiang Y,Wang R,et al.Pan-cancer analysis of RNA methyltransferases identifies FTSJ3 as a potential regulator of breast cancer progression[J].RNA Biol,2020,17(4):474-486.[11]Blanco S,Bandiera R,Popis M,et al.Stem cell function and stress response are controlled by protein synthesis[J].Nature,2016,534(7607):335-340.[12]Yang JC,Risch E,Zhang M,et al.Association of tRNA methyltransferase NSUN2/IGF-II molecular signature with ovarian cancer survival[J].Future Oncol,2017,13(22):1981-1990.[13]Lu L,Zhu G,Zeng H,et al.High tRNA Transferase NSUN2 Gene Expression is Associated with Poor Prognosis in Head and Neck Squamous Carcinoma[J].Cancer Invest,2018,36(4):246-253.[14]Lu L,Gaffney SG,Cannataro VL,et al.Transfer RNA methyltransferase gene NSUN2 mRNA expression modifies the effect of T cell activation score on patient survival in head and neck squamous carcinoma[J].Oral Oncol,2020(101):104554.[15]Mei L,Shen C,Miao R,et al.RNA methyltransferase NSUN2 promotes gastric cancer cell proliferation by repressing p57(Kip2) by an m(5)C-dependent manner[J].Cell Death Dis,2020,11(4):270.[16]Blanco S,Dietmann S,Flores JV,et al.Aberrant methylation of tRNAs links cellular stress to neuro-developmental disorders[J].EMBO J,2014,33(18):2020-2039.[17]Tuorto F,Liebers R,Musch T,et al.RNA cytosine methylation by Dnmt2 and NSun2 promotes tRNA stability and protein synthesis[J].Nat Struct Mol Biol,2012,19(9):900-905.[18]Jeltsch A,Ehrenhofer-Murray A,Jurkowski TP,et al.Mechanism and biological role of Dnmt2 in Nucleic Acid Methylation[J].RNA Biol,2017,14(9):1108-1123.[19]Spriggs KA,Bushell M,Willis AE.Translational regulation of gene expression during conditions of cell stress[J].Mol Cell,2010,40(2):228-237.[20]Gebetsberger J,Zywicki M,Kunzi A,et al.tRNA-derived fragments target the ribosome and function as regulatory non-coding RNA in Haloferax volcanii[J].Archaea,2012(2012):260909.[21]Li Q,Hu B,Hu GW,et al.tRNA-Derived Small Non-Coding RNAs in Response to Ischemia Inhibit Angiogenesis[J].Sci Rep,2016(6):20850.[22]Keam SP,Sobala A,Ten HS,et al.tRNA-Derived RNA Fragments Associate with Human Multisynthetase Complex (MSC) and Modulate Ribosomal Protein Translation[J].J Proteome Res,2017,16(2):413-420.[23]Kato K,Mizuno S,Morton J,et al.Expanding the phenotype of biallelic loss-of-function variants in the NSUN2 gene: Description of four individuals with juvenile cataract, chronic nephritis, or brain anomaly as novel complications[J].Am J Med Genet A,2021,185(1):282-285.
相似文献/References:
[1]吴 刚,袁华兵.阿瑞匹坦对于改善Ⅲ~Ⅳ期颅内胶质瘤患者CINV的研究[J].医学信息,2019,32(13):87.[doi:10.3969/j.issn.1006-1959.2019.13.024]
WU Gang,YUAN Hua-bing.Study on the Effect of Aprepitant on Improving CINV in Patients with
Stage III~IV Intracranial Glioma[J].Medical Information,2019,32(04):87.[doi:10.3969/j.issn.1006-1959.2019.13.024]
[2]张 诚,丁建玲,麦麦提依明·托合提,等.P53、EGFR在胶质瘤组织中的表达及意义[J].医学信息,2020,33(07):94.[doi:10.3969/j.issn.1006-1959.2020.07.026]
ZHANG Cheng,DING Jian-ling,McMatti Yiming Tohetti,et al.Expression and Significance of P53 and EGFR in Glioma Tissues[J].Medical Information,2020,33(04):94.[doi:10.3969/j.issn.1006-1959.2020.07.026]
[3]程 哲,汪潮潮,吴 娟,等.BFAR在胶质瘤中的表达及其与胶质瘤预后的关系[J].医学信息,2021,34(07):78.[doi:10.3969/j.issn.1006-1959.2021.07.021]
CHENG Zhe,WANG Chao-chao,WU Juan,et al.The Expression of BFAR in Glioma and Its Relationship with the Prognosis of Glioma[J].Medical Information,2021,34(04):78.[doi:10.3969/j.issn.1006-1959.2021.07.021]
[4]尹 江,张志杰,贺智敏.miRNA205在神经胶质瘤细胞放疗敏感性中的作用[J].医学信息,2021,34(13):1.[doi:10.3969/j.issn.1006-1959.2021.13.001]
YIN Jiang,ZHANG Zhi-jie,HE Zhi-min.The Role of miRNA205 in the Sensitivity of Glioma Cells to Radiotherapy[J].Medical Information,2021,34(04):1.[doi:10.3969/j.issn.1006-1959.2021.13.001]
[5]刘钰婵,张 威,邱 俊,等.感兴趣区选取数量对脑胶质瘤IVIM参数测量的影响[J].医学信息,2022,35(01):84.[doi:10.3969/j.issn.1006-1959.2022.01.020]
LIU Yu-chan,ZHANG Wei,QIU Jun,et al.The Influence of the Number of Selected ROIs on the Measurement of IVIM Parameters of Glioma[J].Medical Information,2022,35(04):84.[doi:10.3969/j.issn.1006-1959.2022.01.020]
[6]谢 炯,戚 继.PEX基因转染人脐带间充质干细胞的体外培养及鉴定[J].医学信息,2023,36(10):88.[doi:10.3969/j.issn.1006-1959.2023.10.020]
XIE Jiong,QI Ji.In Vitro Culture and Identificationg of Human Umbilical Cord Mesenchymal Stem Cells Modified by PEX Gene[J].Medical Information,2023,36(04):88.[doi:10.3969/j.issn.1006-1959.2023.10.020]
[7]胡彩虹,王志浩,方思琪,等.CARM1在胶质瘤发生发展中的作用研究[J].医学信息,2022,35(06):77.[doi:10.3969/j.issn.1006-1959.2022.06.019]
HU Cai-hong,WANG Zhi-hao,FANG Si-qi,et al.The Role of CARM1 in the Development of Glioma[J].Medical Information,2022,35(04):77.[doi:10.3969/j.issn.1006-1959.2022.06.019]